Related Experiment Video

Updated: Jul 11, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Intranasal desmopressin (Octim): a safe and efficacious treatment option for children with bleeding disorders

K Khair1, K Baker, M Mathias

  • 1Haemophilia Comprehensive Care Centre, Great Ormond Street Hospital for Children NHS Trust, London, UK. khairk@gosh.nhs.uk

Haemophilia : the Official Journal of the World Federation of Hemophilia
|September 21, 2007
PubMed

Insights

A new intranasal desmopressin (1-deamino-8-D-arginine vasopressin (DDAVP)) preparation is effective and well-accepted for children with inherited bleeding disorders. This intranasal route offers a cost-effective treatment option with positive outcomes.

Area of Science:

  • Pediatric Hematology
  • Pharmacology
  • Vascular Biology

Background:

  • Inherited bleeding disorders in children require effective and accessible treatments.
  • Desmopressin (1-deamino-8-D-arginine vasopressin, DDAVP) is an established therapy for these conditions.
  • Previous administration routes include intravenous and subcutaneous injections.

Purpose of the Study:

  • To evaluate the efficacy and acceptability of a novel intranasal desmopressin preparation.
  • To assess the suitability of intranasal DDAVP as a cost-effective treatment for pediatric bleeding disorders.

Main Methods:

  • Clinical assessment of a new intranasal desmopressin formulation.
  • Evaluation of treatment efficacy and patient/caregiver acceptability.
  • Cost-effectiveness analysis compared to existing administration routes.

Main Results:

  • The intranasal desmopressin preparation demonstrated significant efficacy in managing bleeding episodes.
  • The new formulation was found to be well-accepted by pediatric patients and their caregivers.
  • Intranasal administration presents a cost-effective treatment alternative.

Conclusions:

  • Intranasal desmopressin is an effective and acceptable treatment for children with inherited bleeding disorders.
  • This new preparation offers a viable, cost-effective therapeutic option.
  • The intranasal route simplifies administration and improves patient compliance.

Related Concept Videos

Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...